NCT03165942View on ClinicalTrials.gov

Neuroendocrine Response to Oral Alcohol Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Alcohol Abuse
Interventions
OTHER

Alcoholic Beverage

In addition to the oral delivery, an IV line will be placed for the purpose of drawing blood during the MRI session.

OTHER

Non-Alcoholic Beverage

In addition to the oral delivery, an IV line will be placed for the purpose of drawing blood during the MRI session.

DRUG

Ethanol

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT03165942 - Neuroendocrine Response to Oral Alcohol Administration | Biotech Hunter | Biotech Hunter